UnitedHealth Group Incorporated (NYSE:UNH) – Research analysts at Cantor Fitzgerald cut their FY2018 EPS estimates for UnitedHealth Group in a note issued to investors on Sunday. Cantor Fitzgerald analyst S. Halper now anticipates that the healthcare conglomerate will earn $10.80 per share for the year, down from their prior forecast of $10.85. Cantor Fitzgerald has a “Buy” rating and a $225.00 price target on the stock.

UnitedHealth Group (NYSE:UNH) last posted its earnings results on Tuesday, October 17th. The healthcare conglomerate reported $2.66 EPS for the quarter, topping the Thomson Reuters’ consensus estimate of $2.57 by $0.09. UnitedHealth Group had a net margin of 4.50% and a return on equity of 21.52%. The firm had revenue of $50.32 billion for the quarter, compared to analysts’ expectations of $50.38 billion. During the same quarter last year, the firm earned $2.17 EPS. The company’s quarterly revenue was up 8.7% compared to the same quarter last year.

Several other equities analysts have also recently commented on UNH. Cowen reissued an “outperform” rating and set a $220.00 target price (up previously from $175.00) on shares of UnitedHealth Group in a research report on Friday, August 11th. Morgan Stanley lifted their target price on shares of UnitedHealth Group from $210.00 to $215.00 and gave the stock an “overweight” rating in a research report on Thursday, August 17th. Jefferies Group reissued a “buy” rating and set a $215.00 target price on shares of UnitedHealth Group in a research report on Friday, August 18th. UBS reissued an “overweight” rating on shares of UnitedHealth Group in a research report on Thursday, August 24th. Finally, ValuEngine raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a research report on Friday, September 1st. Three equities research analysts have rated the stock with a hold rating and twenty-four have given a buy rating to the company’s stock. The company presently has an average rating of “Buy” and an average price target of $224.56.

UnitedHealth Group (NYSE:UNH) traded down $1.33 during trading on Wednesday, hitting $220.09. 3,246,300 shares of the company’s stock traded hands, compared to its average volume of 3,119,193. UnitedHealth Group has a 1 year low of $156.09 and a 1 year high of $231.77. The company has a debt-to-equity ratio of 0.52, a quick ratio of 0.70 and a current ratio of 0.70. The company has a market cap of $214,570.92, a PE ratio of 23.07, a P/E/G ratio of 1.64 and a beta of 0.66.

A number of hedge funds have recently modified their holdings of UNH. Marshall Wace LLP grew its position in shares of UnitedHealth Group by 441.4% during the 2nd quarter. Marshall Wace LLP now owns 13,935 shares of the healthcare conglomerate’s stock valued at $2,578,000 after purchasing an additional 11,361 shares in the last quarter. American Century Companies Inc. grew its position in shares of UnitedHealth Group by 16.9% during the 2nd quarter. American Century Companies Inc. now owns 4,703,113 shares of the healthcare conglomerate’s stock valued at $872,051,000 after purchasing an additional 681,111 shares in the last quarter. Schwab Charles Investment Management Inc. grew its position in shares of UnitedHealth Group by 5.3% during the 2nd quarter. Schwab Charles Investment Management Inc. now owns 3,656,975 shares of the healthcare conglomerate’s stock valued at $678,077,000 after purchasing an additional 183,401 shares in the last quarter. Essex Financial Services Inc. grew its position in shares of UnitedHealth Group by 12.3% during the 2nd quarter. Essex Financial Services Inc. now owns 8,846 shares of the healthcare conglomerate’s stock valued at $1,640,000 after purchasing an additional 967 shares in the last quarter. Finally, Factory Mutual Insurance Co. grew its position in shares of UnitedHealth Group by 20.9% during the 2nd quarter. Factory Mutual Insurance Co. now owns 416,600 shares of the healthcare conglomerate’s stock valued at $77,245,000 after purchasing an additional 72,000 shares in the last quarter. 86.20% of the stock is currently owned by institutional investors and hedge funds.

In other UnitedHealth Group news, insider Larry C. Renfro sold 50,574 shares of the business’s stock in a transaction on Friday, September 15th. The shares were sold at an average price of $198.11, for a total transaction of $10,019,215.14. Following the sale, the insider now owns 195,625 shares of the company’s stock, valued at approximately $38,755,268.75. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, Director Gail R. Wilensky sold 5,600 shares of the business’s stock in a transaction on Wednesday, November 29th. The shares were sold at an average price of $223.31, for a total transaction of $1,250,536.00. Following the sale, the director now directly owns 61,137 shares in the company, valued at approximately $13,652,503.47. The disclosure for this sale can be found here. Insiders have sold a total of 57,606 shares of company stock worth $11,566,525 in the last three months. Insiders own 0.89% of the company’s stock.

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, December 12th. Shareholders of record on Friday, December 1st will be issued a dividend of $0.75 per share. The ex-dividend date is Thursday, November 30th. This represents a $3.00 dividend on an annualized basis and a yield of 1.36%. UnitedHealth Group’s payout ratio is 33.26%.

COPYRIGHT VIOLATION WARNING: This piece was originally posted by American Banking News and is the property of of American Banking News. If you are viewing this piece on another domain, it was illegally copied and republished in violation of United States & international trademark & copyright legislation. The correct version of this piece can be accessed at https://www.americanbankingnews.com/2017/12/06/unitedhealth-group-incorporated-forecasted-to-earn-fy2018-earnings-of-10-80-per-share-unh.html.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated is a health and well-being company. The Company operates through four segments: UnitedHealthcare, OptumHealth, OptumInsight and OptumRx. It conducts its operations through two business platforms: health benefits operating under UnitedHealthcare and health services operating under Optum.

Earnings History and Estimates for UnitedHealth Group (NYSE:UNH)

Receive News & Ratings for UnitedHealth Group Incorporated Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group Incorporated and related companies with MarketBeat.com's FREE daily email newsletter.